Pancreatitis: A recognized but rare risk is damage to the pancreas due to inflammation
The next wave of medications targets three receptors simultaneously: GLP1, GIP, and the glucagon receptor
The votes are not binding, and the FDA will ultimately decide whether to lift current restrictions on these peptides and make them more easily accessible to people whove been turning to the little-researched but highly popular drugs to improve their health
Pennisi P, Gavrilova O, Setser-Portas J, Jou W, Santopietro S, Clemmons D, Yakar S, LeRoith D
However, its important to consult with a healthcare provider before adding any new medications or supplements to your regimen, as they can provide guidance on appropriate choices and dosages
doi: 10.1016/j.meatsci.2021.108621 106